Compare Sun Pharma with PARENT.DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs PARENT.DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA PARENT.DRUGS SUN PHARMA/
PARENT.DRUGS
 
P/E (TTM) x 32.4 -0.1 - View Chart
P/BV x 4.4 - - View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 SUN PHARMA   PARENT.DRUGS
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
PARENT.DRUGS
Mar-21
SUN PHARMA/
PARENT.DRUGS
5-Yr Chart
Click to enlarge
High Rs6543 20,621.5%   
Low Rs3393 13,023.1%   
Sales per share (Unadj.) Rs139.64.1 3,421.5%  
Earnings per share (Unadj.) Rs9.5-40.8 -23.3%  
Cash flow per share (Unadj.) Rs18.2-35.0 -52.0%  
Dividends per share (Unadj.) Rs7.500-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs193.6-229.0 -84.6%  
Shares outstanding (eoy) m2,399.3429.82 8,046.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.60.7 502.7%   
Avg P/E ratio x52.1-0.1 -73,725.2%  
P/CF ratio (eoy) x27.3-0.1 -33,098.0%  
Price / Book Value ratio x2.60 -20,339.6%  
Dividend payout %78.80-   
Avg Mkt Cap Rs m1,190,43086 1,383,899.2%   
No. of employees `000NANA-   
Total wages/salary Rs m68,622145 47,286.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,981122 275,297.0%  
Other income Rs m8,5921 1,342,453.1%   
Total revenues Rs m343,573122 280,903.5%   
Gross profit Rs m41,616-118 -35,348.5%  
Depreciation Rs m20,800173 12,004.8%   
Interest Rs m1,4141,254 112.8%   
Profit before tax Rs m27,994-1,545 -1,812.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,147-328 -1,571.1%   
Profit after tax Rs m22,847-1,217 -1,877.1%  
Gross profit margin %12.4-96.8 -12.8%  
Effective tax rate %18.421.2 86.7%   
Net profit margin %6.8-1,000.3 -0.7%  
BALANCE SHEET DATA
Current assets Rs m304,421681 44,719.8%   
Current liabilities Rs m161,45611,436 1,411.8%   
Net working cap to sales %42.7-8,839.3 -0.5%  
Current ratio x1.90.1 3,167.6%  
Inventory Days Days149375 39.8%  
Debtors Days Days990-  
Net fixed assets Rs m336,6823,343 10,071.3%   
Share capital Rs m2,399298 804.7%   
"Free" reserves Rs m462,229-7,127 -6,485.7%   
Net worth Rs m464,628-6,829 -6,804.0%   
Long term debt Rs m8,9811,072 837.8%   
Total assets Rs m641,1034,024 15,933.0%  
Interest coverage x20.8-0.2 -8,983.1%   
Debt to equity ratio x0-0.2 -12.3%  
Sales to assets ratio x0.50 1,727.8%   
Return on assets %3.80.9 408.9%  
Return on equity %4.917.8 27.6%  
Return on capital %6.25.0 123.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m84,4930-   
Fx outflow Rs m30,3340-   
Net fx Rs m54,1590-   
CASH FLOW
From Operations Rs m61,7041,253 4,923.6%  
From Investments Rs m5,3621 864,871.0%  
From Financial Activity Rs m-59,805-1,254 4,767.8%  
Net Cashflow Rs m5,964-1 -1,169,451.0%  

Share Holding

Indian Promoters % 54.5 73.3 74.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.8 0.0 338,000.0%  
FIIs % 12.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 26.7 170.4%  
Shareholders   675,908 7,183 9,409.8%  
Pledged promoter(s) holding % 6.5 94.5 6.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

Sensex Tanks 554 Points, Nifty Ends Near 18,100; Maruti, Tech Mahindra & Tata Consumer Plunge 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 18, 2022 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS